Amoxicillin-Clavulanate Dosing for 49 kg, 21-Year-Old Patient
For a 21-year-old patient weighing 49 kg, use standard adult dosing of amoxicillin-clavulanate: 875 mg/125 mg twice daily for respiratory tract infections or more severe infections, or 500 mg/125 mg twice daily for less severe infections. 1
Dosing Rationale
Since this patient weighs ≥40 kg and is an adult, adult dosing recommendations apply rather than weight-based pediatric dosing. The FDA-approved dosing for adults is straightforward 1:
Standard Adult Regimens:
- Less severe infections: 500 mg/125 mg every 12 hours OR 250 mg/125 mg every 8 hours
- More severe infections or respiratory tract infections: 875 mg/125 mg every 12 hours OR 500 mg/125 mg every 8 hours
The choice between these regimens depends on:
- Infection severity: More severe infections warrant the higher dose
- Infection site: Respiratory tract infections specifically benefit from higher dosing (875/125 mg twice daily) 1
- Recent antibiotic exposure: Prior antibiotic use within 4-6 weeks increases resistance risk and favors higher dosing 2
Key Administration Points
Take at the start of meals to enhance clavulanate absorption and minimize gastrointestinal intolerance 1. This is particularly important given that diarrhea occurs in approximately 40% of patients by day 3 of treatment 3.
Critical Dosing Errors to Avoid
- Never substitute two 250 mg/125 mg tablets for one 500 mg/125 mg tablet - they contain the same amount of clavulanate (125 mg each), making this substitution inappropriate 1
- The clavulanate component is fixed at 125 mg in adult formulations due to tolerability concerns 4
Duration of Treatment
Treatment duration varies by indication:
- Acute bacterial rhinosinusitis (adults): 5-7 days 5
- Skin and soft tissue infections: 7-14 days 6
- Community-acquired pneumonia: At least 5 days 7
Special Considerations
While high-dose formulations (4 g amoxicillin daily) exist for resistant pathogens 2, recent evidence shows no additional benefit of high-dose over standard-dose amoxicillin-clavulanate in adults with acute sinusitis 3. The standard 875/125 mg twice daily regimen provides excellent coverage for most community-acquired infections while minimizing adverse effects.
For this 49 kg adult patient, weight-based dosing is unnecessary - standard adult formulations are appropriate and effective 1.